Supporting the role of nectin-4 in cancer progression, it has been shown that blocking nectin-4 with antibodies could inhibit the growth of cell line-derived (18) and patient-derived (23) breast cancer mouse xenografts and augment the antitumor activity of NK cells (21). This evidence concerns the gene NECTIN4 and breast carcinoma.